| abstract |
Stereoisomers useful for treating diseases mediated at least in part by dysregulation of the PIKK signaling pathway (eg mTOR) and useful for modulating PIKK-related kinase signaling such as mTOR Disclosed are compounds of formula I, including isomers, geometric isomers, tautomers, solvates, metabolites, and pharmaceutically acceptable salts. |